HOSPITAL ADMISSIONS AFTER DISCHARGED FROM THE EMERGENCY DEPARTMENT TO HOME WITH COVID-19 TREATMENT
5PSQ-212
NUTRITIONAL SUPPORT AND INTERACTION WITH ONCOLOGICAL TREATMENT IN BREAST CANCER
5PSQ-211
MEDICATION ERRORS RELATING TO SIMILAR OR MISLEADING MANUFACTURER SPECIFIC DRUG PACKAGING AND LABELLING
5PSQ-210
RETROSPECTIVE EVALUATION OF THE DOCUMENTATION OF ALLERGIC AND IDIOSYNCRATIC ADVERSE DRUG REACTIONS IN THE CONTEXT OF THE REQUIREMENTS CONCERNING A CLINICAL DECISION SUPPORT SYSTEM
5PSQ-209
ANTICHOLINERGIC BURDEN AND RISK OF ADVERSE EVENTS IN PATIENTS FROM A SPANISH NURSING HOME
5PSQ-208
PHARMACEUTICAL ALGORITHMS TARGETING ANTICOAGULANT THERAPY: IMPACT OF AVICENNE CLINICAL DECISION SUPPORT IN PATIENT SAFETY
5PSQ-207
ANALYSIS OF THE MEDICINES UNDER ADDITIONAL MONITORING AUTHORISED IN THE EUROPEAN UNION FROM 2017 TO 2019
5PSQ-206
SATISFACTION OF PATIENTS WITH PHARMACEUTICAL TELECARE
5PSQ-205
MANIPULATING TABLETS CONTAINING POORLY SOLUBLE PREDNISOLONE TO OBTAIN PAEDIATRIC DOSES
5PSQ-204
DIFFERENCE IN ADHERENCE ASSOCIATED WITH THE ROUTE OF ADMINISTRATION
5PSQ-203
POLYPHARMACY AND POTENTIALLY INAPPROPRIATE MEDICATIONS IN ELDERLY ONCOHAEMATOLOGICAL PATIENTS REFERRED TO PALLIATIVE CARE: APPLICATION OF THE STOPPFrail CRITERIA
5PSQ-202
BIOSIMILARS IN THE REAL WORLD: RESULTS FROM AN ACTIVE PHARMACOVIGILANCE PROGRAMME IN A PORTUGUESE ONCOLOGY HOSPITAL
5PSQ-201
EFFECT OF SACUBITRIL/VALSARTAN ON GLYCAEMIC CONTROL AND RENAL FUNCTION IN PATIENTS WITH DIABETES AND HEART FAILURE: A MULTI-INSTITUTIONAL COHORT STUDY IN TAIWAN
5PSQ-200
COMPARATIVE CARDIOVASCULAR EVENTS ASSOCIATED WITH DENOSUMAB VERSUS ZOLEDRONATE IN THE ELDERLY: A MULTI-INSTITUTIONAL COHORT STUDY IN TAIWAN
5PSQ-199
USE OF SODIUM GLUCOSE COTRANSPORTER 2 INHIBITORS AND RISK OF FRACTURE IN TYPE 2 DIABETES PATIENTS: A MULTI-INSTITUTIONAL COHORT STUDY IN TAIWAN.
